329 related articles for article (PubMed ID: 17133483)
1. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
Jeong WI; Park O; Radaeva S; Gao B
Hepatology; 2006 Dec; 44(6):1441-51. PubMed ID: 17133483
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.
Jeong WI; Park O; Gao B
Gastroenterology; 2008 Jan; 134(1):248-58. PubMed ID: 18166357
[TBL] [Abstract][Full Text] [Related]
3. Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.
Jeong WI; Park O; Suh YG; Byun JS; Park SY; Choi E; Kim JK; Ko H; Wang H; Miller AM; Gao B
Hepatology; 2011 Apr; 53(4):1342-51. PubMed ID: 21480338
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice.
Weng HL; Feng DC; Radaeva S; Kong XN; Wang L; Liu Y; Li Q; Shen H; Gao YP; Müllenbach R; Munker S; Huang T; Chen JL; Zimmer V; Lammert F; Mertens PR; Cai WM; Dooley S; Gao B
J Hepatol; 2013 Oct; 59(4):738-45. PubMed ID: 23747755
[TBL] [Abstract][Full Text] [Related]
5. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice.
Sun R; Park O; Horiguchi N; Kulkarni S; Jeong WI; Sun HY; Radaeva S; Gao B
Hepatology; 2006 Oct; 44(4):955-66. PubMed ID: 17006930
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis.
Walters DM; Antao-Menezes A; Ingram JL; Rice AB; Nyska A; Tani Y; Kleeberger SR; Bonner JC
Am J Pathol; 2005 Nov; 167(5):1221-9. PubMed ID: 16251407
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
Weng H; Mertens PR; Gressner AM; Dooley S
J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
[TBL] [Abstract][Full Text] [Related]
10. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types.
Wang X; Seo W; Park SH; Fu Y; Hwang S; Rodrigues RM; Feng D; Gao B; He Y
Int J Biol Sci; 2021; 17(4):1153-1167. PubMed ID: 33867837
[No Abstract] [Full Text] [Related]
12. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
Nakamura I; Zakharia K; Banini BA; Mikhail DS; Kim TH; Yang JD; Moser CD; Shaleh HM; Thornburgh SR; Walters I; Roberts LR
PLoS One; 2014; 9(4):e92273. PubMed ID: 24710173
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells.
Choi WM; Ryu T; Lee JH; Shim YR; Kim MH; Kim HH; Kim YE; Yang K; Kim K; Choi SE; Kim W; Kim SH; Eun HS; Jeong WI
Hepatology; 2021 Oct; 74(4):2170-2185. PubMed ID: 33932306
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway.
Guo M; Wang Z; Dai J; Fan H; Yuan N; Gao L; Peng H; Cheng X
Phytomedicine; 2023 Apr; 112():154587. PubMed ID: 36805480
[TBL] [Abstract][Full Text] [Related]
15. The role of Smad3 in mediating mouse hepatic stellate cell activation.
Schnabl B; Kweon YO; Frederick JP; Wang XF; Rippe RA; Brenner DA
Hepatology; 2001 Jul; 34(1):89-100. PubMed ID: 11431738
[TBL] [Abstract][Full Text] [Related]
16. Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice.
Yi HS; Lee YS; Byun JS; Seo W; Jeong JM; Park O; Duester G; Haseba T; Kim SC; Park KG; Gao B; Jeong WI
Hepatology; 2014 Sep; 60(3):1044-53. PubMed ID: 24668648
[TBL] [Abstract][Full Text] [Related]
17. Paeonol alleviates CCl
Wu S; Liu L; Yang S; Kuang G; Yin X; Wang Y; Xu F; Xiong L; Zhang M; Wan J; Gong X
Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):438-445. PubMed ID: 31119954
[No Abstract] [Full Text] [Related]
18. Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.
Lee JI; Wright JH; Johnson MM; Bauer RL; Sorg K; Yuen S; Hayes BJ; Nguyen L; Riehle KJ; Campbell JS
Am J Physiol Cell Physiol; 2016 Mar; 310(6):C436-45. PubMed ID: 26632601
[TBL] [Abstract][Full Text] [Related]
19. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.
Gao B; Radaeva S; Jeong WI
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):173-80. PubMed ID: 19072444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
